MeSH D020181 - obstructive sleep apnea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Alembic Pharmaceuticals | Modafinil | Modafinil | 2012-10-18 | |||
| Allergan | Modafinil | Modafinil | 2012-11-01 | |||
| Apotex | Modafinil | Modafinil | 2014-02-03 | |||
| Appco Pharma | Modafinil | Modafinil | 2017-08-16 | |||
| Atnahs Pharmaceuticals | Solriamfetol | Sunosi | 2020-01-16 | |||
| Aurobindo Pharma | Modafinil | Modafinil | 2012-09-27 | |||
| Bioprojet | Pitolisant | Ozawade | 2021-09-01 | |||
| Cephalon | Modafinil | Provigil | 2023-11-29 | 1998-12-24 | $535.976 M | Q2/10-Q2/11 |
| GSK | Umeclidinium, Fluticasone furoate, Vilanterol | Elebrato Ellipta | 2017-11-15 | |||
| Fluticasone furoate, Vilanterol | Relvar Ellipta | 2013-11-13 | ||||
| Fluticasone furoate, Vilanterol | Revinty Ellipta | 2014-05-02 | ||||
| Umeclidinium, Fluticasone furoate, Vilanterol | Temybric Ellipta | 2019-06-12 | ||||
| Umeclidinium, Fluticasone furoate, Vilanterol | Trelegy Ellipta | 2017-11-15 | ||||
| Fluticasone furoate, Vilanterol | Breo Ellipta | 2022-09-11 | 2013-05-10 | |||
| Hikma Pharmaceuticals | Modafinil | Modafinil | 2012-09-26 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
63%17/27
Phase 2
38%15/40
Phase 3
59%20/34
Approved: 3Overall Success rate: 14%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use